Mangoceuticals, Inc.
$0.51
▼
-6.11%
2026-04-21 08:08:01
www.mangoceuticals.com
NCM: MGRX
Explore Mangoceuticals, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.43 M
Current Price
$0.51
52W High / Low
$2.88 / $0.16
Stock P/E
—
Book Value
$1.13
Dividend Yield
—
ROCE
-62.34%
ROE
-1.42%
Face Value
—
EPS
$-2.17
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
3
Beta
2.55
Debt / Equity
2.02
Current Ratio
1.74
Quick Ratio
1.74
Forward P/E
—
Price / Sales
12.65
Enterprise Value
$4.59 M
EV / EBITDA
-0.29
EV / Revenue
10.06
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | HeartBeam, Inc. | $0.92 | — | $37.8 M | — | -812.1% | -9.87% | $4 / $0.54 | $0.07 |
| 2. | VSee Health, Inc. | $0.24 | — | $11.87 M | — | -476.79% | -5.42% | $2.52 / $0.19 | $-0.33 |
| 3. | Healthcare Triangle, Inc. | $2.47 | — | $4.86 M | — | 89.58% | -1.83% | $7,470 / $2.24 | $17.67 |
| 4. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 5. | Bullfrog AI Holdings, Inc. | $0.99 | — | $18.34 M | — | -308.69% | -1.83% | $2.04 / $0.43 | $0.19 |
| 6. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 7. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.09 M | 0.08 M | 0.17 M | 0.11 M | 0.11 M | — |
| Operating Profit | -1.49 M | -7.54 M | -5.27 M | -4.85 M | -2.4 M | — |
| Net Profit | -2.77 M | -7.62 M | -5.42 M | -4.84 M | -1.95 M | — |
| EPS in Rs | -0.16 | -0.45 | -0.32 | -0.29 | -0.11 | -1.14 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.46 M | 0.62 M | 0.73 M | 0.01 M |
| Operating Profit | -19.15 M | -8.69 M | -9.22 M | -1.99 M |
| Net Profit | -20.64 M | -8.71 M | -9.21 M | -2 M |
| EPS in Rs | -1.22 | -0.51 | -0.54 | -0.12 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 16.09 M | 15.37 M | 1.05 M | 1 M |
| Total Liabilities | 0.89 M | 1.43 M | 0.28 M | 0.39 M |
| Equity | 15.2 M | 13.95 M | 0.77 M | 0.61 M |
| Current Assets | 1.55 M | 0.08 M | 0.84 M | 0.69 M |
| Current Liabilities | 0.89 M | 1.43 M | 0.21 M | 0.26 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -5.85 M | -4.86 M | -7 M | -1.35 M |
| Investing CF | 0 M | 0.07 M | -0 M | -0.04 M |
| Financing CF | 7.27 M | 4.13 M | 7.06 M | 2.05 M |
| Free CF | -5.85 M | -4.86 M | -7 M | -1.39 M |
| Capex | — | — | -0 M | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -25.96% | -15.81% | 8083.16% | — |
| Earnings Growth % | -137.11% | 5.5% | -361.07% | — |
| Profit Margin % | -4526.76% | -1413.63% | -1259.4% | -22352.11% |
| Operating Margin % | -4200.46% | -1411.58% | -1260.28% | -22279.7% |
| Gross Margin % | 54.91% | 61.7% | 58.99% | 54.26% |
| EBITDA Margin % | -4126.07% | -1292.81% | -1248.48% | -22236.48% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-10-16 | 1:0.0666667 |